NCT02803749View on ClinicalTrials.gov

Buspirone in Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

January 25, 2019

Conditions
Parkinson DiseaseAnxiety
Interventions
DRUG

Buspirone

DRUG

Placebo

Trial Locations (1)

14618

University of Rochester Medical Center, Rochester

All Listed Sponsors
collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

lead

University of Rochester

OTHER

NCT02803749 - Buspirone in Parkinson's Disease | Biotech Hunter | Biotech Hunter